184 related articles for article (PubMed ID: 21079728)
21. Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury.
Bao H; Ge Y; Zhuang S; Dworkin LD; Liu Z; Gong R
Kidney Int; 2012 Apr; 81(7):662-73. PubMed ID: 22258319
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice.
Cuzzocrea S; Crisafulli C; Mazzon E; Esposito E; Muià C; Abdelrahman M; Di Paola R; Thiemermann C
Br J Pharmacol; 2006 Nov; 149(6):687-702. PubMed ID: 17016509
[TBL] [Abstract][Full Text] [Related]
23. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.
Wang Z; Bao H; Ge Y; Zhuang S; Peng A; Gong R
Br J Pharmacol; 2015 Feb; 172(3):895-909. PubMed ID: 25262943
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin stimulates proliferation of adult hippocampal neural stem/progenitor cells through activation of p38 mitogen-activated protein kinase (p38MAPK)/glycogen synthase kinase 3β (GSK-3β)/β-catenin signaling cascade.
Zhang D; Guo M; Zhang W; Lu XY
J Biol Chem; 2011 Dec; 286(52):44913-20. PubMed ID: 22039048
[TBL] [Abstract][Full Text] [Related]
26. Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Di Paola R; Mazzon E; Crisafulli C; Genovese T; Muià C; Abdelrahman M; Esposito E; Thiemermann C
Shock; 2007 Jan; 27(1):97-107. PubMed ID: 17172987
[TBL] [Abstract][Full Text] [Related]
27. GSK-3β Inhibitor Induces Expression of the TLR4/MyD88/NF-κB Signaling Pathway to Protect Against Renal Ischemia-Reperfusion Injury During Rat Kidney Transplantation.
Su S; Zhang P; Zhang Q; Yin Z
Inflammation; 2019 Dec; 42(6):2105-2118. PubMed ID: 31440938
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
29. Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.
Collino M; Aragno M; Castiglia S; Tomasinelli C; Thiemermann C; Boccuzzi G; Fantozzi R
Diabetes; 2009 Jan; 58(1):235-42. PubMed ID: 18840784
[TBL] [Abstract][Full Text] [Related]
30. First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.
Martinez A; Alonso M; Castro A; Pérez C; Moreno FJ
J Med Chem; 2002 Mar; 45(6):1292-9. PubMed ID: 11881998
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of glycogen synthase kinase-3β prevents activation of focal adhesion kinase after ischemia/reperfusion of the rat lung.
Waldow T; Witt W; Matschke K
Clin Hemorheol Microcirc; 2010; 46(2-3):169-81. PubMed ID: 21135492
[TBL] [Abstract][Full Text] [Related]
32. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β.
Choi CH; Lee BH; Ahn SG; Oh SH
Biochem Biophys Res Commun; 2012 Feb; 418(4):759-64. PubMed ID: 22310719
[TBL] [Abstract][Full Text] [Related]
33. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
[TBL] [Abstract][Full Text] [Related]
34. GSK-3β inhibitor TDZD-8 prevents reduction of aquaporin-1 expression via activating autophagy under renal ischemia reperfusion injury.
Liu Q; Kong Y; Guo X; Liang B; Xie H; Hu S; Han M; Zhao X; Feng P; Lyu Q; Dong W; Liang X; Wang W; Li C
FASEB J; 2021 Aug; 35(8):e21809. PubMed ID: 34314052
[TBL] [Abstract][Full Text] [Related]
35. GSK3beta promotes apoptosis after renal ischemic injury.
Wang Z; Havasi A; Gall J; Bonegio R; Li Z; Mao H; Schwartz JH; Borkan SC
J Am Soc Nephrol; 2010 Feb; 21(2):284-94. PubMed ID: 20093356
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
38. Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma.
Miyashita K; Kawakami K; Nakada M; Mai W; Shakoori A; Fujisawa H; Hayashi Y; Hamada J; Minamoto T
Clin Cancer Res; 2009 Feb; 15(3):887-97. PubMed ID: 19188159
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.
Chen H; Yang S; Yang Z; Ma L; Jiang D; Mao J; Jiao B; Cai Z
J Cell Biochem; 2007 Dec; 102(5):1281-9. PubMed ID: 17427960
[TBL] [Abstract][Full Text] [Related]
40. The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β.
Ogbomo H; Biru T; Michaelis M; Loeschmann N; Doerr HW; Cinatl J
Biochem Pharmacol; 2011 Jan; 81(2):251-8. PubMed ID: 20934407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
